Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-12-9
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-838X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1718, 1721
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9371003-Adverse Drug Reaction Reporting Systems,
pubmed-meshheading:9371003-Humans,
pubmed-meshheading:9371003-Pharmaceutical Preparations,
pubmed-meshheading:9371003-Physician's Role,
pubmed-meshheading:9371003-United States,
pubmed-meshheading:9371003-United States Food and Drug Administration
|
pubmed:year |
1997
|
pubmed:articleTitle |
Monitoring for adverse drug events.
|
pubmed:publicationType |
Editorial,
Comment
|